Prohaszka Zoltan
Semmelweis Egyetem
H-index: 61
Europe-Hungary
Top articles of Prohaszka Zoltan
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
Natural Autoantibodies in Biologic-Treated Rheumatoid Arthritis and Ankylosing Spondylitis Patients: Associations with Vascular Pathophysiology | International Journal of Molecular Sciences | Diána Simon Dorottya Kacsándi Anita Pusztai Boglárka Soós Edit Végh | 2024/3/18 |
Open ADAMTS-13 conformation index predicts earlier relapse in immune-mediated thrombotic thrombocytopenic purpura | Journal of Thrombosis and Haemostasis | Laure De Waele Kazuya Sakai Ilaria Mancini György Sinkovits Tanja Falter | 2024/2/1 |
Complement C7 and clusterin form a complex in circulation | Frontiers in Immunology | Mariam Massri Erik JM Toonen Bettina Sarg Leopold Kremser Marco Grasse | 2024/1/25 |
Storage of Transfusion Platelet Concentrates Is Associated with Complement Activation and Reduced Ability of Platelets to Respond to Protease-Activated Receptor-1 and … | International Journal of Molecular Sciences | Linnea I Andersson Dick J Sjöström Huy Quang Quach Kim Hägerström Lisa Hurler | 2024/1/16 |
Circulating mortalin in blood and activation of the alternative complement pathway as risk indicators in COVID-19 infection | Frontiers in Immunology | Maya Avraham György Sinkovits Lisa Hurler Zoltán Prohászka Zvi Fishelson | 2024/4/23 |
Use of eculizumab in children with allogeneic haematopoietic stem cell transplantation associated thrombotic microangiopathy-a multicentre retrospective PDWP and IEWP EBMT study | Bone Marrow Transplantation | Peter Svec Reem Elfeky Jacques-Emmanuel Galimard Christine S Higham Arnaud Dalissier | 2023/2 |
Differentiating between activation via the lectin or the classical complement pathway in patients with systemic lupus erythematosus | Clinical and Experimental Immunology | Mads Lamm Larsen Anne Troldborg Erik JM Toonen Lisa Hurler Zoltan Prohaszka | 2023/10/1 |
Infekciók kockázatának csökkentése veleszületett és szerzett komplementdefektusokban. | Éva Karászi Beáta Onozó Andrea Kulcsár János Szlávik Vera Goda | 2023/6/25 | |
96 Association between acute stage biomarker levels, severity and long-term outcome in COVID-19 | Immunobiology | Lisa Hurler Federica Mescia Laura Bergamaschi Erika Kajdácsi György Sinkovits | 2023/9/1 |
The Rationale of Complement Blockade of the MCPggaac Haplotype following Atypical Hemolytic Uremic Syndrome of Three Southeastern European Countries … | Daniel Turudic Danka Pokrajac Velibor Tasic Dino Kasumovic Zoltan Prohaszka | 2023/8/22 | |
Immunosuppressive Therapy of Antibody-Mediated aHUS and TTP | International Journal of Molecular Sciences | Kata Kelen Orsolya Horváth Éva Kis Bálint Mikes Péter Sallay | 2023/9/21 |
Reducing the risk of infections in hereditary and acquired complement deficiencies. | Éva Karászi Beáta Onozó Andrea Kulcsár János Szlávik Vera Goda | 2023/6/25 | |
Class switch towards spike protein-specific IgG4 antibodies after SARS-CoV-2 mRNA vaccination depends on prior infection history | Scientific Reports | Petra Kiszel Pál Sík János Miklós Erika Kajdácsi György Sinkovits | 2023/8/13 |
181 Complement C7 and clusterin form a stable complex in circulation | Immunobiology | Mariam Massri Erik JM Toonen Bettina Sarg Leopold Kremser Marco Grasse | 2023/9/1 |
Complement lectin pathway activation is associated with COVID-19 disease severity, independent of MBL2 genotype subgroups | Frontiers in immunology | Lisa Hurler Ágnes Szilágyi Federica Mescia Laura Bergamaschi Blanka Mező | 2023/3/27 |
182 Complement C7 and clusterin form a stable complex in circulation | Immunobiology | Mariam Massri Erik JM Toonen Bettina Sarg Leopold Kremser Marco Grasse | 2023/9/1 |
Complement-mediated thrombotic microangiopathy related to COVID-19 or SARS-CoV-2 vaccination | Kidney International Reports | Christof Aigner Martina Gaggl Sophie Schmidt Renate Kain Nicolas Kozakowski | 2023/8/1 |
Caplacizumab Therapy in Immune Thrombotic Thrombocytopenic Purpura | Blood | Marienn Réti György Sinkovits Andrea Várkonyi Ágnes Király Zita Farkas | 2023/11/28 |
Hemolytic uremic syndrome in the setting of COVID-19 successfully treated with complement inhibition therapy: An instructive case report of a previously healthy toddler and … | Frontiers in pediatrics | Matija Matošević Ivanka Kos Maša Davidović Maja Ban Hana Matković | 2023/2/15 |
MAP‐2: CD55 chimeric construct effectively modulates complement activation | The FASEB Journal | Lydia González‐del‐Barrio Laura Pérez‐Alós Leon Cyranka Anne Rosbjerg Simon Nagy | 2023/11 |
